Femasys Inc
NASDAQ:FEMY
EV/OCF
Enterprise Value to OCF
Enterprise Value to Operating Cash Flow (EV/OCF) ratio is a valuation multiple that measures the value of a company, debt included, to the operating cash flow it generates.
Market Cap | EV/OCF | ||||
---|---|---|---|---|---|
US |
Femasys Inc
NASDAQ:FEMY
|
26.7m USD | -1.2 | ||
US |
Abbott Laboratories
NYSE:ABT
|
182.2B USD | 26.3 | ||
US |
Intuitive Surgical Inc
NASDAQ:ISRG
|
137.2B USD | 77.4 | ||
US |
Stryker Corp
NYSE:SYK
|
125.9B USD | 38.7 | ||
IE |
Medtronic PLC
NYSE:MDT
|
110.1B USD | 19.6 | ||
US |
Boston Scientific Corp
NYSE:BSX
|
108.3B USD | 46.6 | ||
US |
Becton Dickinson and Co
NYSE:BDX
|
68.1B USD | 23.6 | ||
DE |
Siemens Healthineers AG
XETRA:SHL
|
58.7B EUR | 29.2 | ||
US |
Edwards Lifesciences Corp
NYSE:EW
|
52.2B USD | 57 | ||
CN |
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
371.8B CNY | 28.1 | ||
US |
Dexcom Inc
NASDAQ:DXCM
|
50.3B USD | 62.2 |
EV/OCF Forward Multiples
Forward EV/OCF multiple is a version of the EV/OCF ratio that uses forecasted operating cash flow for the EV/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.